IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Fusion Pharm Inc (FSPM)

Q1 2026 vs Q3 2026

Comparing institutional holders between quarters

Quarters

Q3 2026Q1 2026Q3 2025Q2 2025Q1 2025
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile
Ascentis Independent Advisors
UNCHANGED
Shares2,000 from 2,000
Change0 (0%)
Value$0 ($0)
Filed 2026-11-03
Status
Ascentis Independent Advisors
UNCHANGED2,0002,00000%$0$0$02026-11-03
Showing 1 of 1 institutions